Expert Discusses Chinese Biosimilar Business Prospects in the European Union

A consultant who specializes in helping Chinese biosimilar companies market their products in the European Union discusses the challenges and opportunities.

Jenny Hao, pharma operating partner with Convergence Partners, is a biosimilars consultant who spoke recently at the Terrapinn Festival of Biologics meeting in Basel, Switzerland. In this video, she speaks with Tony Hagen, senior editor for The Center for Biosimilars® about the interest Chinese biosimilars producers have in Europe and the challenges they face. The prospects for biosimilar sales in China are huge, but there are many companies in the market battling for share, and so they are slowly turning in the direction of sales abroad, including the European Union, she explains. However, in entering the European Union they must go up against many large and well-established biopharmaceutical companies. Ultimately, market share will go to the most efficient and economical producers, Hao says.

Related Videos
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
Michael Kleinrock
Here are the top 5 biosimilar articles for the week of February 13th, 2023.
Michael Kleinrock
Ian Henshaw
Ryan Haumschild, PharmD, MS, MBA
Ryan Haumdschild, PharmD
Ryan Haumschild, PharmD
Ryan Haumschild, PharmD
Julie M. Reed
Related Content
© 2023 MJH Life Sciences

All rights reserved.